Medinet News

Medinet: Independent Officer Registration Form

Jan 24 17:30

Medinet: Notice regarding the recording of special profit (profit from sale of investment securities)

Jan 6 12:15

Medinet: Notice Concerning Election of Director Candidates and Audit & Supervisory Board Candidates

Nov 22, 2024 14:30

Medinet: Notice Concerning Decrease in Capital and Capital Reserve Amounts and Disposal of Surplus Funds

Nov 22, 2024 14:30

Medinet: Notice regarding the recording of non-operating income and extraordinary losses

Nov 13, 2024 14:30

Medinet: Summary of Financial Results 2024

Nov 13, 2024 14:30

Medinet: Explanatory materials on business plans and growth potential

Nov 13, 2024 14:30

Medinet: [Progress of disclosure matters] Decision to discontinue development of regenerative medicine products for the purpose of treating chronic heart failure

Nov 8, 2024 14:30

Medinet: Notice regarding mass exercise and completion of exercise of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment

Sep 11, 2024 15:00

Medinet: Strategic partnership agreement signed with AGC for cell therapy CDMO business

Sep 11, 2024 10:00

Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third-party allotment

Sep 2, 2024 14:00

Medinet: Announcements of individual stocks regarding the recognition of non-operating revenue.

Aug 9, 2024 14:00

Medinet: Overview of Q3 2024 financial results.

Aug 9, 2024 14:00

Medinet: Started manufacturing outsourcing for a new specified cell processed product ("S-DSC") related to hair regeneration.

Aug 8, 2024 14:00

Medinet: (Progress of disclosure matters) **** regulatory authorities have approved the provision of γδT cell therapy at new medical institutions (progress of licensing agreement with Medigen Biotechnology Corp.)

Jul 8, 2024 14:00

Medinet: Notice Concerning the Recording of Non-Operating Income and Non-Operating Expenses

May 10, 2024 14:00

Medinet: Summary of financial results for the 2nd quarter of 2024

May 10, 2024 14:00

Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third-party allotment

May 1, 2024 14:00

Medinet: (Progress of disclosure matters) Taiwan regulatory authorities approve provision of gamma-delta T cell therapy at new medical institutions

Apr 1, 2024 14:15

Medinet: Notice regarding the monthly exercise status of the 19th Stock Acquisition Rights (with exercise price amendment clause) through third party allotment

Apr 1, 2024 14:00